{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:57:17Z","timestamp":1793141837339,"version":"4.5.0"},"reference-count":16,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:sec id=\"ab-ebr260002-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">MBD4<\/jats:italic>\n                      monoallelic germline pathogenic and likely pathogenic variants have recently been identified as predisposing to uveal melanoma, a rare primary intraocular tumor, with an estimated 9.15-fold increased risk of developing the disease for pathogenic variant carriers.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ebr260002-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To assess the risk of developing uveal melanoma for carriers of the\n                      <jats:italic toggle=\"yes\">MBD4<\/jats:italic>\n                      monoallelic germline pathogenic variant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ebr260002-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>\n                      In a case series involving 896 individuals, including 319 who were previously evaluated, germline target-sequencing of\n                      <jats:italic toggle=\"yes\">MBD4<\/jats:italic>\n                      was offered to every new patient with uveal melanoma at Curie Institute from February 2021 to September 2025. Non-Finnish European participants from the Genome Aggregation Database were used as a reference population.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ebr260002-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>Diagnosis of uveal melanoma genetic predisposition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ebr260002-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>\n                      Prevalence of\n                      <jats:italic toggle=\"yes\">MBD4<\/jats:italic>\n                      variants.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ebr260002-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 23 of 896 patients were identified as carrying an\n                      <jats:italic toggle=\"yes\">MBD4<\/jats:italic>\n                      germline pathogenic or likely pathogenic variant, corresponding to a relative risk of 31.44 (95% CI, 18.18-53.00) of developing uveal melanoma compared with the general population (2-sided Fisher exact test,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ebr260002-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>\n                      These findings confirm that\n                      <jats:italic toggle=\"yes\">MBD4<\/jats:italic>\n                      is an important predisposing gene to uveal melanoma in the French population. This reinforces a strategy of broad patient screening given the therapeutic implications and the consequences of genetic counseling.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2026.1071","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:31:46Z","timestamp":1777563106000},"page":"536","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence of the Predisposing Gene\n                    <i>MBD4<\/i>\n                    for Uveal Melanoma"],"prefix":"10.1001","volume":"144","author":[{"given":"Ana\u00efs","family":"Le Ven","sequence":"first","affiliation":[{"name":"Department of Genetics, Institut Curie, Paris, France"},{"name":"Paris Sciences & Lettres Research University, Paris, France"},{"name":"Inserm U1339 CNRS UMR3666, DNA Repair and Uveal Melanoma (DRUM), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Charlotte","family":"Villy","sequence":"additional","affiliation":[{"name":"Paris Sciences & Lettres Research University, Paris, France"},{"name":"Inserm U1339 CNRS UMR3666, DNA Repair and Uveal Melanoma (DRUM), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Le Mentec","sequence":"additional","affiliation":[{"name":"Department of Genetics, Institut Curie, Paris, France"},{"name":"Paris Sciences & Lettres Research University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Houy","sequence":"additional","affiliation":[{"name":"Paris Sciences & Lettres Research University, Paris, France"},{"name":"Inserm U1339 CNRS UMR3666, DNA Repair and Uveal Melanoma (DRUM), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Dubois d\u2019Enghien","sequence":"additional","affiliation":[{"name":"Department of Genetics, Institut Curie, Paris, France"},{"name":"Paris Sciences & Lettres Research University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Matet","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, Paris, France"},{"name":"Department of Ocular Oncology, Institut Curie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Malaise","sequence":"additional","affiliation":[{"name":"Paris Sciences & Lettres Research University, Paris, France"},{"name":"Department of Ocular Oncology, Institut Curie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Bubien","sequence":"additional","affiliation":[{"name":"Department of Genetics, Institut Bergoni\u00e9, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Lortholary","sequence":"additional","affiliation":[{"name":"Medical Oncology, GINECO-H\u00f4pital Priv\u00e9 du Confluent, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Ait Omar","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, AP-HP, H\u00f4pital Avicenne, Bobigny, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Stoppa-Lyonnet","sequence":"additional","affiliation":[{"name":"Department of Genetics, Institut Curie, Paris, France"},{"name":"Inserm U1339 CNRS UMR3666, DNA Repair and Uveal Melanoma (DRUM), Paris, France"},{"name":"Universit\u00e9 Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Cassoux","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, Paris, France"},{"name":"Department of Ocular Oncology, Institut Curie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Paris Sciences & Lettres Research University, Paris, France"},{"name":"Inserm U1339 CNRS UMR3666, DNA Repair and Uveal Melanoma (DRUM), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Golmard","sequence":"additional","affiliation":[{"name":"Department of Genetics, Institut Curie, Paris, France"},{"name":"Paris Sciences & Lettres Research University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Henri","family":"Stern","sequence":"additional","affiliation":[{"name":"Department of Genetics, Institut Curie, Paris, France"},{"name":"Paris Sciences & Lettres Research University, Paris, France"},{"name":"Inserm U1339 CNRS UMR3666, DNA Repair and Uveal Melanoma (DRUM), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrystelle","family":"Colas","sequence":"additional","affiliation":[{"name":"Department of Genetics, Institut Curie, Paris, France"},{"name":"Paris Sciences & Lettres Research University, Paris, France"},{"name":"Inserm U1339 CNRS UMR3666, DNA Repair and Uveal Melanoma (DRUM), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"13","key":"ebr260002r1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1167\/iovs.64.13.45","article-title":"Worldwide incidence of ocular melanoma and correlation with pigmentation-related risk factors.","volume":"64","author":"Wu","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"ebr260002r2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","article-title":"Uveal melanoma.","volume":"6","author":"Jager","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"ebr260002r3","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1038\/s41467-018-04322-5","article-title":"Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors.","volume":"9","author":"Rodrigues","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"ebr260002r4","doi-asserted-by":"publisher","first-page":"9864","DOI":"10.1038\/s41467-024-54223-z","article-title":"Base-excision repair pathway shapes 5-methylcytosine deamination signatures in pan-cancer genomes.","volume":"15","author":"Silveira","year":"2024","journal-title":"Nat Commun"},{"key":"ebr260002r5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ejca.2022.06.033","article-title":"MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients.","volume":"173","author":"Saint-Ghislain","year":"2022","journal-title":"Eur J Cancer"},{"issue":"5-6","key":"ebr260002r6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00251-019-01108-x","article-title":"Prolonged stable disease in a uveal melanoma patient with germline MBD4 nonsense mutation treated with pembrolizumab and ipilimumab.","volume":"71","author":"Johansson","year":"2019","journal-title":"Immunogenetics"},{"issue":"18","key":"ebr260002r7","doi-asserted-by":"publisher","first-page":"5513","DOI":"10.1158\/1078-0432.CCR-19-1215","article-title":"Evolutionary routes in metastatic uveal melanomas depend on MBD4 alterations.","volume":"25","author":"Rodrigues","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"1","key":"ebr260002r8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/jnci\/djaa047","article-title":"Germline MBD4 mutations and predisposition to uveal melanoma.","volume":"113","author":"Derrien","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"ebr260002r9","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1093\/jnci\/djad248","article-title":"Familial uveal melanoma and other tumors in 25 families with monoallelic germline MBD4 variants.","volume":"116","author":"Villy","year":"2024","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"ebr260002r10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ajo.2010.08.047","article-title":"Appropriate use and reporting of uncontrolled case series in the medical literature.","volume":"151","author":"Kempen","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"ebr260002r11","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/pcmr.12892","article-title":"Germline loss-of-function variants in MBD4 are rare in Finnish patients with uveal melanoma.","volume":"33","author":"Repo","year":"2020","journal-title":"Pigment Cell Melanoma Res"},{"issue":"2","key":"ebr260002r12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/ng.2523","article-title":"Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma.","volume":"45","author":"Harbour","year":"2013","journal-title":"Nat Genet"},{"issue":"12","key":"ebr260002r13","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1136\/jmedgenet-2011-100156","article-title":"Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.","volume":"48","author":"Abdel-Rahman","year":"2011","journal-title":"J Med Genet"},{"issue":"10","key":"ebr260002r14","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/ng.910","article-title":"Germline mutations in BAP1 predispose to melanocytic tumors.","volume":"43","author":"Wiesner","year":"2011","journal-title":"Nat Genet"},{"issue":"8","key":"ebr260002r15","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1001\/jamaophthalmol.2015.1119","article-title":"Clinical characteristics of uveal melanoma in patients with germline BAP1 mutations.","volume":"133","author":"Gupta","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"ebr260002r16","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1038\/s41467-020-16276-8","article-title":"Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours.","volume":"11","author":"Johansson","year":"2020","journal-title":"Nat Commun"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2847894\/jamaophthalmology_le_ven_2026_br_260002_1781021798.93909.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:00:52Z","timestamp":1781794852000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2847894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2026.1071","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}